$4.45
0.184.22%
Last update: 8:34 AM
15 minutes delayed
Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FATE | Fate Therapeutics | -$0.54 | -$0.47 | — | — | $933.00K | $1.41M | — | — | 08/06/2024 | Get Alert |
FATE | Fate Therapeutics | -$0.19 | -$0.49 | -$0.47 | 4.08% | $58.98M | $1.11M | $1.93M | 73.42% | 05/09/2024 | Get Alert |
FATE | Fate Therapeutics | -$0.58 | -$0.52 | -$0.45 | 13.46% | $44.36M | $1.59M | $1.68M | 5.41% | 02/26/2024 | Get Alert |
FATE | Fate Therapeutics | -$0.86 | -$0.57 | -$0.46 | 19.30% | $14.98M | $890.00K | $1.94M | 118.43% | 11/08/2023 | Get Alert |
FATE | Fate Therapeutics | -$0.79 | -$0.59 | -$0.54 | 8.47% | $18.55M | $5.53M | $933.00K | -83.13% | 08/08/2023 | Get Alert |
FATE | Fate Therapeutics | -$0.68 | -$0.62 | -$0.19 | 69.35% | $18.41M | $35.50M | $58.98M | 66.14% | 05/03/2023 | Get Alert |
FATE | Fate Therapeutics | -$0.72 | -$0.86 | -$0.58 | 32.56% | $17.07M | $16.72M | $44.36M | 165.29% | 02/28/2023 | Get Alert |
FATE | Fate Therapeutics | -$0.45 | -$0.89 | -$0.86 | 3.37% | $14.22M | $15.63M | $14.98M | -4.15% | 11/03/2022 | Get Alert |
FATE | Fate Therapeutics | -$0.58 | -$0.82 | -$0.79 | 3.66% | $13.41M | $12.91M | $18.55M | 43.68% | 08/03/2022 | Get Alert |
FATE | Fate Therapeutics | -$0.48 | -$0.76 | -$0.68 | 10.53% | $11.14M | $9.40M | $18.41M | 95.89% | 05/04/2022 | Get Alert |
FATE | Fate Therapeutics | -$0.61 | -$0.67 | -$0.72 | -7.46% | $15.90M | $10.73M | $17.07M | 59.06% | 02/28/2022 | Get Alert |
FATE | Fate Therapeutics | -$0.68 | -$0.58 | -$0.45 | 22.41% | $7.56M | $7.89M | $14.22M | 80.29% | 11/04/2021 | Get Alert |
FATE | Fate Therapeutics | -$0.35 | -$0.53 | -$0.58 | -9.43% | $5.46M | — | $13.41M | — | 08/04/2021 | Get Alert |
FATE | Fate Therapeutics | -$0.44 | -$0.43 | -$0.48 | -11.63% | $2.52M | $5.90M | $11.14M | 88.85% | 05/05/2021 | Get Alert |
FATE | Fate Therapeutics | -$0.37 | -$0.39 | -$0.61 | -56.41% | $2.80M | $4.87M | $15.90M | 226.41% | 02/24/2021 | Get Alert |
FATE | Fate Therapeutics | -$0.40 | -$0.36 | -$0.68 | -88.89% | $2.43M | $6.97M | $7.56M | 8.44% | 11/05/2020 | Get Alert |
FATE | Fate Therapeutics | -$0.36 | -$0.27 | -$0.35 | -29.63% | $2.82M | $13.23M | $5.46M | -58.69% | 08/05/2020 | Get Alert |
FATE | Fate Therapeutics | -$0.30 | -$0.39 | -$0.44 | -12.82% | $2.63M | $1.80M | $2.52M | 39.72% | 05/11/2020 | Get Alert |
FATE | Fate Therapeutics | -$0.25 | -$0.39 | -$0.37 | 5.13% | $1.66M | $1.80M | $2.80M | 55.67% | 03/02/2020 | Get Alert |
FATE | Fate Therapeutics | -$0.31 | -$0.38 | -$0.40 | -5.26% | $1.03M | $1.79M | $2.43M | 35.70% | 11/05/2019 | Get Alert |
FATE | Fate Therapeutics | -$0.37 | -$0.33 | -$0.36 | -9.09% | $1.03M | — | $2.82M | — | 08/06/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.47 | $-0.49 | 4.08 % |
Dec 2023 | 2024-02-26 | $-0.45 | $-0.52 | 13.5 % |
Sep 2023 | 2023-11-08 | $-0.46 | $-0.57 | 19.3 % |
Jun 2023 | 2023-08-08 | $-0.54 | $-0.59 | 8.47 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $1.93M | $1.11M | 73.4 % |
Dec 2023 | 2024-02-26 | $1.68M | $1.59M | 5.41 % |
Sep 2023 | 2023-11-08 | $1.94M | $890.00K | 118.4 % |
Jun 2023 | 2023-08-08 | $933.00K | $5.53M | -83.1 % |
Fate Therapeutics (FATE) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.47, which beat the estimate of $-0.49.
The Actual Revenue was $1.9M, which beat the estimate of $1.1M.
Browse earnings estimates, EPS, and revenue on all stocks.